Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma

Weill Cornell Medical College, New York

Mount Sinai Medical Center, New York

Winship Cancer Institute., Atlanta

Investigative Clinical Research Of Indiana, Llc, Indianapolis

Mid Dakota Clinic, Pc, Bismarck

University Of Chicago Medical Center, Chicago

Washington University School Of Medicine, St Louis

Sharp Clinical Oncology Research, San Diego

Yale University School Of Medicine, New Haven

Va Connecticut Healthcare System, West Haven

Dana Farber Cancer Institute, Boston

Dana-Farber Cancer Institute, Boston